Ozempic May Blunt Metabolic Effects of Antipsychotics

(Medage today) – A GLP -1 receptor agonist can help improve metabolic profiles for some schizophrenia under antipsychotic patients, the historic randomized trial said. Among 154 schizophrenia patients with prediabetes and overweight or obesity …